Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: J Genet Couns. 2020 Nov 3;30(3):911–918. doi: 10.1002/jgc4.1351

State of Recent Literature on Communication About Cancer Genetic Testing among Latinx Populations

Daniel Chavez-Yenter 1,2, Wen-Ying Sylvia Chou 3, Kimberly A Kaphingst 1,2
PMCID: PMC8730654  NIHMSID: NIHMS1636934  PMID: 33142015

Abstract

Cancer-related Genetic Testing (hereafter CGT) has transformed cancer prevention, treatment, and care. Researchers debate whether diffusion and use of genetic testing will reduce or widen cancer health disparities through effects on improving or worsening cancer-related mortality, morbidity, and outcomes that disproportionately affect racial and ethnic minority populations. Cancer disparities by race and ethnicity have been associated with social determinants of health and healthcare access and experience. However, little research has explored how communication about CGT may contribute to these disparities. As such, the goal of this study was to characterize the literature published between 2010 and 2017 on communication about CGT among Latinx populations through a secondary analysis of papers identified in a larger scoping review. We found thirteen (2.5%) of 513 papers in the parent scoping review had over 50% Latinx representation; only nine of these (69%) had fully Latinx comprised study cohorts. The majority of the 13 identified studies (n=9) were conducted to assess knowledge and attitudes regarding CGT. Most studies included services or materials in both Spanish and English. Few studies assessed language preference or acculturation or compared outcomes across sub-ethnicities. We identified opportunities for researchers to explore differences in outcomes by language preference and acculturation, and between sub-ethnicities in future studies. Leveraging a greater understanding of the heterogeneity within the Latinx population will allow genetics researchers and providers to improve utilization of CGT and therein health outcomes to advance health equity.

Keywords: Latinx/Latino, Cancer, Disparities, Genetic Testing, Scoping Review, Communication


Cancer Genetic Testing (CGT) has transformed cancer prevention, treatment, care (Kensler et al., 2016). Researchers have debated whether diffusion and use of genetic testing will reduce or widen cancer health disparities through effects on improving or worsening cancer-related mortality, morbidity, and outcomes that disproportionately affect racial and ethnic minority populations (Smith et al., 2016). Data have shown that while genetic testing has been instrumental for identification and clinical management of individuals with inherited cancers, racial and ethnic minority populations are not benefiting from testing and improved health outcomes at the same rates as White populations (Halbert & Harrison, 2018). These disparities in access to and outcomes of genetic testing by race and ethnicity have been linked to social determinants of health (e.g., socioeconomic status, education level, discrimination, segregation) and healthcare access and experiences (Galea et al., 2011; Moy & Freeman, 2014; Canedo et al., 2019). In order to further understand the mechanisms underlying these disparities, the current analysis aimed to describe the recent research on communication about CGT with Latinx populations by conducting a secondary analysis of papers that were identified through a parent scoping review on communication about CGT (Kaphingst et al., 2019).

Latinx is the gender-neutral term for Latino/a and refers to any individuals with origins from Latin America (Aragones et al., 2014). Although not a homogeneous population, Latinx members share language and aspects of history and, as such, are typically combined into a single category for research studies (Cruz-Correa et al., 2016; Aragones et al., 2014). Previous research has found Latinx utilization of CGT to be lower than Whites (Cruz-Correa et al., 2016). A recent national study found that the BRCA1/2 genetic testing rate among Latina women was 18% compared to 30% for White women (Levy et al., 2017). Another study related to colorectal cancer found a CGT rate of 3.1% for Latinx individuals compared to 10.7% for non-Hispanic Whites (Hall et al., 2012). These findings are consistent with the theory of Diffusion of Innovation, which describes how newer technologies and services often are distributed unevenly with racial and ethnic minority groups having access later than those more socially privileged (Rogers, 2003).

While disparities in use of genetic testing have been documented for various cancers (e.g., breast, colorectal, liver) (Levy et al., 2017; Canedo et al., 2019; Pagán et al 2009; Kinney et al 2010), potential explanations of these testing disparities have varied, including lack of awareness, associated costs, low levels of interest, adverse psychological consequences, and limited health literacy (Cruz-Correa et al., 2016; Canedo et al., 2019; Kinney et al., 2010; Sussner et al., 2013). Even when offered CGT related to Lynch Syndrome and hereditary breast and ovarian cancer, Latinx populations are less likely to test (Butrick et al., 2015; Hall et al., 2012; Muller et al., 2018). Prior empirical research related to CGT has suggested that the uneven distribution of testing may be due to both individual-level factors (i.e., awareness, knowledge, attitudes) (Pagán et al 2009; Singer et al., 2004; Kinney et al 2010; Bloss et al., 2018) and system-level factors (i.e., insurance, access, trust) (Singer et al., 2004; Peters, Rose & Armstrong, 2004; Roberts, Mensah, & Khoury, 2019). As system-level factors, prior research has found that primary care physicians that serve minority (and indeed non-minority) populations tend to have less knowledge of specialized topics (i.e., genetics) and may be less likely to refer patients to genetic counseling and testing (Armstrong et al., 2007; Hauser et al., 2018; Haga et al., 2019; Shields, Burke, & Levy, 2008). As primary care providers may not feel knowledgeable about this technology, unless they have had a personalized genetic testing experience, they often do not refer their patients to testing (Haga et al., 2019). Canedo and colleagues (2019) completed a systematic review of genetic testing among different racial/ethnic subgroups and found that Black and Latinx populations had significantly more concerns about genetic testing if they were aware of it, but often they were unaware of genetic testing. Other studies have found that lack of awareness is one of the largest barriers to testing among Latinx populations (Canedo et al., 2019; Cruz-Correa et al., 2016; Levy et al., 2017).

Communication about CGT likely affects differences in awareness and utilization of this testing. Kinney and colleagues (2006) found that primary care physicians discussed BRCA1/2 genetic testing significantly less with Latina women compared to White women (Kinney et al., 2006). Despite this initial finding, the research on communication about CGT with Latinx patients and communities has not been well characterized. The current analysis reviewed seven years of published papers that had a majority of participants who were Latinx. These papers were initially identified through a parent scoping review, which was conducted to characterize research on communication about CGT as a whole (Kaphingst et al., 2019). The goals of the present analysis were to describe the state of this communication literature focused on Latinx communities and identify opportunities to enhance communication with Latinx communities about CGT.

The parent scoping review (Kaphingst et al., 2019) utilized the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRIMSA) guidelines (Moher et al., 2009). A literature review of six databases identified English-language articles related to communication about CGT with patients and the general public published between January 2010 and January 2017 (Kaphingst et al., 2019). Broad search terms included cancer, genetic/genomic, communication, provider/direct-to-consumer, and patient/public. The scoping review characterized general study information, outcomes or themes, cancer and genetic focus, participant characteristics, and the return of results process. The present analysis focused on those identified studies with a majority (i.e., over 50%) Latinx participants based on the study’s definition of Latinx, consistent with the parent scoping review. For the studies meeting this inclusion criterion, we assessed definition of Latinx, study design, language(s) utilized, genetic services offered (genetic testing and counseling were offered to participants), outcomes, group comparisons (if applicable), and key findings.

Thirteen (2.5%) of the 513 papers in the parent scoping review had over 50% Latinx representation; only nine of the 13 papers (69%) had fully Latinx comprised study cohorts. The studies focused on a wide range of research questions, including baseline knowledge and attitudes towards CGT, process of communication about CGT, and how test results were returned and communicated to clients. The majority of the 13 identified studies (n=9) were conducted to assess knowledge and attitudes regarding CGT (Table 1). Qualitative and quantitative designs were used equally, with five studies having a mixed methods design. Most of the studies (n=9) had psychosocial outcomes as the main type of outcome. For study locations, seven of the 13 studies were situated in United States (U.S.) coastal cities (i.e., New York, Burbank, Tampa), three in Texas, two in the Intermountain West (Salt Lake City and Albuquerque), and one study was conducted outside the U.S., in Cuba.

Table 1 –

Study CHARACTERISTICS of Reviewed Articles

Author(s) / Year / Site Definition of Latinx Main Outcomes Genetic Services Offered? Methodology Language(s) Group Comparison Key Findings
Chalela et al., 2012 / Hidalgo County, TX, USA Latina Women Psychosocial (Knowledge, Attitudes, behavioral intention to CGT) No Qualitative Interviews English & Spanish Level of Education Key Latino values of religiosity, family, and influence of healthcare providers play an important role in awareness and attitudes towards CGT1 and should be considered in designing interventions.
Gibbon, 2011 / Cuba Cuban women Psychosocial (genetic knowledge, identify, and family) No Ethnography & Qualitative Interviews Spanish Cuban Regions Cuban healthcare institutions still face challenges of misinformation or misunderstandings of cancer diagnoses and genetic testing results contexts with Cuban women patients.
Kinney et al., 2010 / Salt Lake City, UT, USA General eligibility requirement included identifying oneself as Hispanic or Latino Psychosocial (Attitudes, beliefs and communication preferences of CGT) No Qualitative Interviews English & Spanish Level of Education, Sex, and Community Leadership Roles Latinx members have low awareness of CGT and its benefits. CGT communication efforts should utilize bilingual media and cultural perspectives to improve access and implementation.
Kukafka et al., 2015 / New York City, NY, USA Hispanic (self-reported), English-speaking Women Decision Making No Mixed Methods (Quantitative & Qualitative) English Race & Numeracy The web-based decision aid, RealRisks, improved perceived breast cancer risk, but barriers remained including distrust of healthcare systems, uncertainty of results, and access to care.
MacDonald et al., 2012 / Burbank, CA, USA Eligible invitees were Latinos with a personal or family history of breast or ovarian cancers Psychosocial, Process of CGT Communication, Return of Results Outcomes Yes Mixed Methods (Quantitative & Qualitative) Spanish CGT Patients vs Non-Patients Following return of CGT results, Latina women should include informational and psychosocial support using patient/family centered conferences to address disparities in CGT engagement.
Mette et al., 2016 / South Texas, USA Patients were of Hispanic background Process of CGT Communication Yes Quantitative English & Spanish Race, SES, Education, Age Through a developed video-teleconferencing risk assessment and consulting of CGT, the intervention was noted as an acceptable method of providing cancer risk assessment for remote and underserved populations.
Rodríguez et al., 2017 / Albuquerque, NM, USA Spanish-Fluency and Spanish-preference Psychosocial (Knowledge and understanding of Skin Cancer risk materials) No Qualitative Interviews (Cognitive Interviews) Spanish Education Level & Materials reviewed Spanish translated skin cancer genomic risk education materials (SOMBRA) were successful in improving awareness and perceived risk by Latinx participants.
Sussner et al., 2015 (a) / New York City, NY, USA Women self-identifying as Latina Psychosocial (Knowledge, Attitudes, Acculturation) Yes Mixed Methods (Quantitative & Qualitative) English & Spanish Age, History of Cancer, Interview Format Personal and community awareness of CGT was low for all participants. Main motivations for CGT was concerns of learning about family members’ cancer status with the main barrier being competing demands. Younger Latinx women were more interested in CGT compared to older Latinx women.
Sussner et al., 2010 (b) / New York City, NY, USA Women self-identifying as Hispanic/Latina Psychosocial (Interests and beliefs of CGT) Yes Mixed Methods (Quantitative & Qualitative) English & Spanish (participant preference) Individual Interview vs Focus Group Despite low awareness and knowledge of CGT, Latina women reported interest in the technology. Culturally tailored education materials including narratives may increase knowledge and contribute to improving CGT engagement.
Sussner et al., 2013 (c) / New York City, NY, USA Women who self-identified as Latinas Psychosocial (Barriers, Facilitators, Interest, Beliefs of CGT) Yes Quantitative Telephone Interviews English & Spanish Age, History of Cancer, Interview Format Educational interventions are needed to promote BRCA genetic counseling among at-risk Latinas and promote referrals from physicians by discussing perceived barriers.
Vadaparampil et al., 2010 (a) / Tampa, FL, USA Hispanic women who self-identified as Mexican, Puerto Rican, or Cuban. Psychosocial (Knowledge and Attitudes towards CGT) No Mixed Methods (Quantitative & Qualitative) English & Spanish (participant preference) Sub-ethnicity (Mexican, Puerto Rican and Cuban) All participants with a personal/family history of breast cancer have similar rates of awareness of their risk, knowledge of and concerns of CGT. However, Cuban women wanted more messages of urgency with results compared to Mexican and Puerto Rican women. Cuban and Mexican women also held more fatalistic attitudes towards CGT results compared to Puerto Rican women. These sub-ethnic differences should be further explored and used in genetic counseling settings.
Vadaparampil et al., 2011 (b) / Tampa, FL, USA & Puerto Rico Eligible participants were self-identifying Puerto Rican women residing in Tampa or Puerto Rico Psychosocial (Knowledge and Attitudes) No Mixed Methods (Quantitative & Qualitative) Unclear (English appeared to be the language used) Puerto Rican Women living in Puerto Rico vs in Tampa, FL All participants were interested in receiving CGT for breast cancer noting that the best facilitator to them would be their provider’s recommendation, but commonly cited the barrier of cost. Improving recruitment by eliminating costs can improve Latinx CGT engagement.
Woodson et al., 2015 / Houston, TX, USA Self-reported demographics (Hispanic) Decision Making & Return of Results Outcomes Yes Quantitative English & Spanish CGT Patients vs Non-Patients Through retrospective electronic health record review, a group-counseling model was most success in engaging racial/ethnic participants, but lack of transportation, limited patient knowledge of family cancer history, and language barriers remain challenges in delivering CGT care. A long-term genetic clinic in a community hospital with group-counseling is recommended to improve CGT engagement.
1

– CGT = Cancer Genetic Testing

2

– SOMBRA = The Skin Health Online for Melanoma: Better Risk Assessment

Definitions of Latinx varied among the studies. Eleven studies used self-reporting to identify Latinx participants while the other two used language (Spanish fluency) or geographic location (Cuba) as a proxy for Latinx identity. Ten of the 11 studies utilizing self-report did not formally define Latinx in their methods section. Only five of the 13 studies overall defined Latinx or Hispanic, generally in the introduction. Country of origin and Spanish-language preference were also used as proxies for characterizing Latinx identity with four of the 13 studies using these variables as groupings in comparisons (i.e., sub-group ethnicity, language preference). Only two studies (15%) assessed acculturation and compared CGT rates by accultration level. In the nine studies fully comprised of Latinx participants, only two (20%), both by Vadaparampil and colleagues in 2010 and 2011, compared sub-ethnicities within Latinx communities (i.e., Puerto Rican, Cuban, Mexican). Among the four studies that included participants from different racial and ethnic groups (e.g., Black, Asian), none compared Latinx sub-ethnicities.

The distribution of language preference varied across studies, ranging from 20%−60% of participants having a preference for Spanish compared to English. In examining the language in which genetic services were offered, we found that most of the studies (n=10) provided the research materials (i.e., genetic services, printed marketing materials, educational materials, questionnaires, interview and focus group protocols) in both English and Spanish, while three used only Spanish. Of the studies fully comprised of Latinx participants, all nine offered services and/or research protocols and materials in English and Spanish by bilingual service providers or research staff. Six of the 13 studies (46%) had genetic counselors delivering services, in each there was at least one bilingual genetic counselor for non-English speaking clients. The remaining studies had research staff delivering research materials and/or services (e.g., skin cancer materials translation, individual interview/focus group facilitation) in either English or Spanish, dependent upon the study population and outcomes of interest for the study. It was unclear if research staff delivering these research materials and/or services were credentialed in genetics but to our interpretation they appeared to be knowledgeable regarding the topic. However, a lack of genetic credentials of research staff that are bilingual may contribute to lower utilization of CGT among Latinx members.

Our study is the first to characterize published research on communication about CGT focused on Latinx populations. The findings from this analysis show that there is a critical need for greater research focused on Latinx communities within this literature. From 2010 to 2017, only 13 of more than 500 published studies on communication about CGT had a majority of participants who were Latinx, and even fewer assessed sub-ethnicities. We found the published research in this area used both qualitative and quantitative methods. The most common research focus was assessment of knowledge and attitudes about CGT, and the studies had primarily psychosocial outcomes. Although examination of these outcomes is crucial to the advancement of engagement with Latinx populations, there were few studies assessing behavioral outcomes of CGT, highlighting a gap in the literature. Additionally, only six studies offered genetic services delivered by genetic counselors, highlighting another gap of limited implementation studies conducted with Latinx populations. As a strength of this literature, we found bilingual language offerings common, which is likely to broaden recruitment efforts. However, few studies compared sub-ethnicity characteristics like language preference that could influence CGT outcomes. These findings therefore highlight gaps in the literature on communication about CGT and opportunities for future research.

Often Latinx communities are treated like a homogeneous population in health research (Aragones et al., 2014). However, with the variety of Latin American cultures, demographic characteristics, and ancestral origins, Latinx communities are highly heterogeneous. This is a common challenge in health research with Latinx populations, as often definitions of Latinidad (Latinness) are reliant on self-identification as Latino/Hispanic or not; this type of designation, however, can lose predictive power when aggregated. Keeping the definition of Latinx broad can improve recruitment (Aragones et al., 2014) while adhering to the U.S. federal definition of Hispanic/Latinx as an ethnic background distinct from race (U.S. Census Bureau, 2020). Ethnic origin relates generally to a social definition recognized in this country rather than biological, anthropological, or genetic criteria (U.S. Census Bureau, 2020). However, use of other variables such as language preference, acculturation, and sub-ethnicity demographics within the broad Latinx categorization allows better characterization of the heterogeneity within this population and warrants further exploration.

In this analysis, we identified an opportunity for greater examination of language preference. The reviewed studies presented findings and implications regardless of the language in which services, outcomes, or research protocols were delivered. While language preference may not play a role in all outcomes related to communication about CGT, additional investigation of differences in outcomes or effect modification by language preference is needed. The potential importance of language preference for intervention design has been recognized in terms of overall intervention success (Wilkin et al., 2007). We recommend that language preference should be assessed within Latinx comprised cohorts with reporting of whether or not differences in outcomes are observed by language preference, especially if bilingual materials are offered.

We found only two studies that assessed acculturation, highlighting another important gap in the literature on communication about CGT. In one example, Sussner and colleagues (2015) compared interest in CGT by acculturation. Language preference has historically been used as a proxy for acculturation, until the latter began to emerge as a separate predictor for psychosocial and health outcomes (Schwartz et al., 2010). Recent research has found that more acculturated Latinx youth generally are more receptive to using technological innovations compared to those who are less acculturated (Landry et al., 2015), suggesting that acculturation may impact utilization of CGT. More generally, utilization of novel technologies has been characterized as a benefit of biculturalism (belonging to two distinct cultures) and acculturation (Benet-Martínez & Haritatos, 2005), both of which have been noted to contribute to better psychosocial well-being and health outcomes compared to those who are monocultural or less acculturated (Coatsworth et al., 2005). While the research on communication about CGT has utilized few measures of acculturation, greater use of such measures could have implications for research and practice. It is important to provide culturally tailored and appropriate materials to Latinx patients (Hann et al., 2017). Acculturation measures could be one way of helping those developing genetic communication materials for Latinx patients. For example, materials and services might be tailored in terms of the most appropriate language or platform for delivery (e.g., mobile phones, Telenovelas, Spanish language radio). Leveraging knowledge of acculturation and language preference could enhance the ability of genetics researchers and providers to diffuse CGT more broadly and encourage participation in future studies.

While acculturation and language preference capture some key characteristics of a Latinx participant, it is also important for researchers to study Latinx populations by sub-ethnicity. Only two studies in our review from the same research team compared sub-ethnicities (Vadaparampil et al., 2010; Vadaparampil et al., 2011). The lack of detailed characterization of the heterogeneity within Latinx populations (e.g., values, beliefs, language) will likely lead to barriers and delays in translating clinical care and policies to the broader population (Aragones et al., 2014). Prior research indicates that health disparities within Latinx communities may go undetected if ethnicity (Latino/Hispanic) is the only demographic characteristic assessed (Eamranond et al., 2009; Chen et al., 2011; Pinheiro et al., 2011; Keegan et al., 2010). As efforts continue, it will be essential to compare Latinx sub-ethnicities to better understand how differences between communities influence awareness of, access to, and use of CGT. For example, data suggest that Cuban and Puerto Rican women are more aware of, have greater access to, and utilize CGT to a greater extent than those of Mexican origin (Cruz-Correa et al., 2017). The Institute of Medicine and Department of Health and Human Services have noted the importance of characterizing Latinx individuals in research beyond ethnicity; nativity, language preference, acculturation, number of years in the U.S., and sub-ethnicity all may uncover health disparities and contribute to a better understanding of disparities within and between population subgroups (Institute of Medicine, 2009; U.S. Department of Human Health Services, 2015)

Despite our novel findings, the analysis is not without limitations. Our analysis focused on papers published from 2010–2017 and there may have been additional research completed outside this timeframe. Because few studies have been conducted with Latinx populations, we could not conduct a meta-analysis or generate effect sizes. Finally, we only included studies published in English, so there is the possibility of Spanish-language published research on communication about CGT. Despite these limitations, this analysis is the first to characterize the lack of Latinx representation in the literature on communication about CGT. Greater community engagement and partnerships with community-based organizations may improve participation in research studies through inclusive language and messaging and outreach through appropriate platforms. We also recommend that researchers highlight language preference differences, assess acculturation, and compare outcomes within sub-ethnicities in future studies as part of efforts to improve access to CGT among Latinx populations. With a more robust understanding of the heterogeneity within the Latinx population, researchers, genetics providers and counselors, and policymakers can improve utilization of CGT and therein health outcomes to advance health equity.

What is known about this topic:

Latinx populations have higher morbidity and mortality from many cancers and lower utilization of genetic testing.

What this paper adds to the topic:

This study is the first to characterize the state of recent literature on communication about cancer genetic testing among Latinx populations. We identified opportunities for researchers to explore differences in outcomes by language preference and acculturation, and between sub-ethnicities, in future studies to better inform delivery of cancer genetic services to these populations.

Acknowledgements

Financial support was provided by the National Cancer Institute’s Behavioral Research Program through HHSN261201700078P. We also acknowledge the direct financial support for the research reported in this publication provided by the Huntsman Cancer Foundation. The opinions expressed by the authors are their own and this material should not be interpreted as representing the official viewpoint of the U.S. Department of Health and Human Services, the National Institutes of Health or the National Cancer Institute.

Footnotes

Conflict of Interest

Daniel Chavez-Yenter, Wen-Ying Sylvia Chou, and Kimberly A. Kaphingst declare that they have no conflict of interests.

Compliance with Ethical Standards

Human Studies and Informed Consent

No human subjects were involved with this research study.

Animal studies

No non-human animal studies were carried out with this study.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Aragones A, Hayes SL, Chen MH, González J, & Gany FM (2014). Characterization of the Hispanic or Latino Population in Health Research: A Systematic Review. Journal of Immigrant and Minority Health, 16(3), 429–439. 10.1007/s10903-013-9773-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. (2005). Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. Journal of the American Medical Association, 293, 1729–1736. [DOI] [PubMed] [Google Scholar]
  3. Benet-Martínez V, Haritatos J. (2005). Bicultural identity integration (BII): Components and psychosocial antecedents. Journal of Personality, 73, 1015–1050. [DOI] [PubMed] [Google Scholar]
  4. Bloss CS, Stoler J, Schairer CE, Rosenthal SB, Cheung C, Rus HM, … Wellis D (2018). Characteristics of likely precision medicine initiative participants drawn from a large blood donor population. Health Affairs, 37, 786–792. [DOI] [PubMed] [Google Scholar]
  5. Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, Graves K, Feeley L, Isaacs C, & Valdimarsdottir HB (2015). Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genetics in Medicine, 17(6), 467–475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Canedo JR, Miller ST, Myers HF, & Sanderson M (2019). Racial and ethnic differences in knowledge and attitudes about genetic testing in the US: Systematic review. Journal of Genetic Counseling, 28(3), 587–601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chalela P, Pagán JA, Su D, Muñoz E, & Ramirez AG (2012). Breast cancer genetic testing awareness, attitudes and intentions of Latinas living along the US-Mexico border: A qualitative study. Journal of Community Medicine & Health Education, 2, 152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chen NE, Gallant JE, Page KR (2011). A systematic review of HIV/AIDS survival and delayed diagnosis among hispanics in the United States. Journal of Immigrant and Minority Health, 14(1), 65–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coatsworth JD, Maldonado‐Molina M, Pantin H, & Szapocznik J (2005). A person‐centered and ecological investigation of acculturation strategies in Hispanic immigrant youth. Journal of Community Psychology, 33(2), 157–174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cruz-Correa M, Pérez-Mayoral J, Dutil J, Echenique M, Mosquera R, Rivera-Román K, … & Pardo S (2017). Clinical cancer genetics disparities among Latinos. Journal of genetic counseling, 26(3), 379–386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eamranond PP, Legedza AT, Diez-Roux AV, et al. (2009). Association between language and risk factor levels among Hispanic adults with hypertension, hypercholesterolemia, or diabetes. American Heart Journal, 157(1), 53–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Galea S, Tracy M, Hoggatt KJ, DiMaggio C, & Karpati A (2011). Estimated deaths attributable to social factors in the United States. American Journal of Public Health, 101(8), 1456–1465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gibbon S (2011). Family medicine, ‘La Herencia’ and breast cancer; understanding the (dis) continuities of predictive genetics in Cuba. Social Science & Medicine, 72(11), 1784–1792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Haga SB, Kim E, Myers RA, & Ginsburg GS (2019). Primary care physicians’ knowledge, attitudes, and experience with personal genetic testing. Journal of personalized medicine, 9(2), 29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hall MJ, Manne SL, Myers RE, Keenan EM, Balshem AM, & Weinberg DS (2012). Predictors of patient uptake of colorectal cancer gene environment risk assessment. Genome Medicine, 4(11), 92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Halbert CH, & Harrison BW (2018). Genetic counseling among minoritypopulations in the era of precision medicine. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 178(1), 68–74. [DOI] [PubMed] [Google Scholar]
  17. Hann KE, Freeman M, Fraser L, Waller J, Sanderson SC, Rahman B, … & PROMISE study team. (2017). Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review. BMC public health, 17(1), 503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hauser D, Obeng AO, Fei K, Ramos MA, & Horowitz CR (2018). Views of primary care providers on testing patients for genetic risks for common chronic diseases. Health Affairs, 37(5), 793–800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Institute of Medicine. (2009). Race, ethnicity, and language data: standardization for health care quality improvement. Retreived May 26, 2020 from: https://www.ahrq.gov/sites/default/files/publications/files/iomracereport.pdf [PubMed]
  20. Kaphingst KA, Peterson E, Zhao J, Gaysynsky A, Elrick A, Hong SJ, Krakow M, Pokharel M, Ratcliff CL, & Klein WM (2019). Cancer communication research in the era of genomics and precision medicine: A scoping review. Genetics in Medicine, 21(8), 1691–1698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Keegan TH, Quach T, Shema S, Glaser SL, Gomez SL (2010). The influence of nativity and neighborhoods on breast cancer stage at diagnosis and survival among California Hispanic women. BMC Cancer. 10, 603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kensler TW, Spira A, Garber JE, Szabo E, Lee JJ, Dong Z, Dannenberg AJ, Hait WN, Blackburn E, & Davidson NE (2016). Transforming cancer prevention through precision medicine and immune-oncology. Cancer Prevention Research, 9(1), 2–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kinney AY, Simonsen SE, Baty BJ, Mandal D, Neuhausen SL, Seggar K, … & Smith K (2006). Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred. Journal of Genetic Counseling, 15(4), 293–305. [DOI] [PubMed] [Google Scholar]
  24. Kinney AY, Gammon A, Coxworth J, Simonsen SE, & Arce-Laretta M (2010). Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genetics in Medicine, 12(2), 105–115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kukafka R, Yi H, Xiao T, Thomas P, Aguirre A, Smalletz C, David R, & Crew K (2015). Why breast cancer risk by the numbers is not enough: Evaluation of a decision aid in multi-ethnic, low-numerate women. Journal of Medical Internet Research, 17(7), e165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Landry M, Vyas A, Turner M, Glick S, & Wood S (2015). Evaluation of Social Media Utilization by Latino Adolescents: Implications for Mobile Health Interventions. JMIR MHealth and UHealth, 3(3), e89. 10.2196/mhealth.4374 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Levy DE, Byfield SD, Comstock CB, Garber JE, Syngal S, Crown WH, & Shields AE. (2011). Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genetics in Medicine, 13(4), 349–355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. MacDonald DJ, Deri J, Ricker C, Perez MA, Ogaz R, Feldman N, Viveros LA, Paz B, Weitzel JN, & Blazer KR (2012). Closing the loop: An interactive action-research conference format for delivering updated medical information while eliciting Latina patient/family experiences and psychosocial needs post-genetic cancer risk assessment. Familial Cancer, 11(3), 449–458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mette LA, Pulido Saldívar A, Poullard NE, Torres IC, Seth SG, Pollock BH, & Tomlinson GE (2016). Reaching high-risk underserved individuals for cancer genetic counseling by video-teleconferencing. Journal of Community and Supportive Oncology, 14(4), 162–168. [DOI] [PubMed] [Google Scholar]
  30. Moher D, Liberati A, Tetzlaff J, & Altman DG (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine, 151(4), 264–269. [DOI] [PubMed] [Google Scholar]
  31. Moy E, & Freeman W (2014). Federal investments to eliminate racial/ethnic health-care disparities. Public Health Reports, 129(1_suppl2), 62–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Muller C, Lee SM, Barge W, Siddique SM, Berera S, Wideroff G, Tondon R, Chang J, Peterson M, & Stoll J (2018). Low referral rate for genetic testing in racially and ethnically diverse patients despite universal colorectal cancer screening. Clinical Gastroenterology and Hepatology, 16(12), 1911–1918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pagán JA, Su D, Li L, Armstrong K, & Asch DA (2009). Racial and ethnic disparities in awareness of genetic testing for cancer risk. American journal of preventive medicine, 37(6), 524–530. [DOI] [PubMed] [Google Scholar]
  34. Pinheiro PS, Williams M, Miller EA, Easterday S, Moonie S, Trapido EJ (2011). Cancer survival among Latinos and the Hispanic Paradox. Cancer Causes Control, 22(4), 553–561. [DOI] [PubMed] [Google Scholar]
  35. Peters N, Rose A, & Armstrong K (2004). The association between race and attitudes about predictive genetic testing. Cancer Epidemiology and Prevention Biomarkers, 13(3), 361–365. [PubMed] [Google Scholar]
  36. Roberts MC, Mensah GA, & Khoury MJ (2019). Leveraging implementation science to address health disparities in genomic medicine: examples from the field. Ethnicity & disease, 29(Suppl 1), 187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rodríguez VM, Robers E, Zielaskowski K, González CJ, Hunley K, Kaphingst KA, Guest DD, Sussman A, White KAM, & Schwartz MR (2017). Translation and adaptation of skin cancer genomic risk education materials for implementation in primary care. Journal of Community Genetics, 8(1), 53–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rogers EM (2003). Diffusion of innovations. New York, NY: Simon and Schuster. [Google Scholar]
  39. Schwartz SJ, Unger JB, Zamboanga BL, & Szapocznik J (2010). Rethinking the concept of acculturation: implications for theory and research. American Psychologist, 65(4), 237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Singer E, Antonucci T, & Van Hoewyk J (2004). Racial and ethnic variations in knowledge and attitudes about genetic testing. Genetic testing, 8(1), 31–43. [DOI] [PubMed] [Google Scholar]
  41. Shields AE, Burke W, Levy DE. (2008). Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genetics in Medicine, 10, 404–414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Smith CE, Fullerton SM, Dookeran KA, Hampel H, Tin A, Maruthur NM, Schisler JC, Henderson JA, Tucker KL, & Ordovás JM (2016). Using genetic technologies to reduce, rather than widen, health disparities. Health Affairs, 35(8), 1367–1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sussner KM, Edwards T, Villagra C, Rodriguez MC, Thompson HS, Jandorf L, & Valdimarsdottir HB (2015). BRCA genetic counseling among at-risk Latinas in New York City: New beliefs shape new generation. Journal of Genetic Counseling, 24(1), 134–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sussner KM, Jandorf L, Thompson HS, & Valdimarsdottir HB (2010). Interest and beliefs about BRCA genetic counseling among at-risk Latinas in New York City. Journal of Genetic Counseling, 19(3), 255–268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sussner KM, Jandorf L, Thompson HS, & Valdimarsdottir HB (2013). Barriers and facilitators to BRCA genetic counseling among at‐risk Latinas in New York City. Psycho‐Oncology, 22(7), 1594–1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. U.S. Census Bureau (2020). About the Hispanic Population and it’s Origin. Retrieved June 8, 2020 from: https://www.census.gov/topics/population/hispanic-origin/about.html
  47. U.S. Department of Health and Human Services (2015). Report to Congress on Minority Health Activities. Retrieved May 27, 2020 from: https://minorityhealth.hhs.gov/Assets/pdf/2015_0916_Report_to_Congress_on_Minority_Health_Activities_FINAL.pdf
  48. Vadaparampil ST, Wideroff L, Breen N, Trapido E. (2006). The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey. Cancer Epidemiology, Biomarkers & Prevention, 15, 618–623. [DOI] [PubMed] [Google Scholar]
  49. Vadaparampil ST, McIntyre J, & Quinn GP (2010). Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: Similarities and variations by sub-ethnicity. Journal of Genetic Counseling, 19(6), 618–629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Vadaparampil ST, Quinn GP, Gjyshi A, & Pal T (2011). Development of a brochure for increasing awareness of inherited breast cancer in black women. Genetic Testing and Molecular Biomarkers, 15(1–2), 59–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Wilkin HA, Valente TW, Murphy S, Cody MJ, Huang G, & Beck V (2007). Does entertainment-education work with Latinos in the United States? Identification and the effects of a telenovela breast cancer storyline. Journal of Health Communication, 12(5), 455–469. [DOI] [PubMed] [Google Scholar]
  52. Woodson AH, Profato JL, Rizvi SH, Elsayegh N, Rieber AG, & Arun BK (2015). Service delivery model and experiences in a cancer genetics clinic for an underserved population. Journal of Health Care for the Poor and Underserved, 26(3), 784–791. [DOI] [PubMed] [Google Scholar]

RESOURCES